| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 2.62B | 2.15B | 1.95B | 1.82B | 1.86B |
| Gross Profit | 1.27B | 2.00B | 1.66B | 754.10M | 884.30M |
| EBITDA | 1.59B | 1.19B | 992.70M | 1.18B | 1.19B |
| Net Income | 586.80M | 264.70M | 126.90M | 204.90M | -56.80M |
Balance Sheet | |||||
| Total Assets | 18.13B | 16.77B | 15.65B | 14.53B | 14.44B |
| Cash, Cash Equivalents and Short-Term Investments | 1.79B | 1.67B | 1.40B | 340.40M | 240.90M |
| Total Debt | 11.49B | 10.79B | 10.00B | 8.44B | 7.98B |
| Total Liabilities | 15.89B | 14.77B | 13.60B | 12.02B | 11.48B |
| Stockholders Equity | 2.24B | 2.00B | 2.06B | 2.51B | 2.96B |
Cash Flow | |||||
| Free Cash Flow | -110.20M | -79.90M | -19.00M | 93.50M | 305.90M |
| Operating Cash Flow | 1.38B | 918.10M | 745.10M | 787.50M | 934.40M |
| Investing Cash Flow | -1.48B | -987.20M | -731.40M | -593.40M | -639.70M |
| Financing Cash Flow | 221.40M | 358.80M | 1.04B | -85.00M | -809.70M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
66 Neutral | $17.65B | 18.10 | 5.60% | 3.62% | 6.62% | 11.55% | |
59 Neutral | £28.03B | 23.07 | 9.45% | 2.98% | 0.54% | -2.65% | |
59 Neutral | £7.82B | 37.36 | 1.68% | 2.86% | -2.11% | -104.48% | |
58 Neutral | £9.58B | 15.16 | 27.72% | 4.45% | 21.96% | 121.69% | |
56 Neutral | £60.31B | 18.27 | 8.47% | 4.15% | -3.76% | 8.20% | |
55 Neutral | £8.58B | 23.49 | 20.35% | 4.50% | 16.66% | 61.25% | |
48 Neutral | £2.17B | 23.89 | 6.61% | 6.56% | 23.25% | ― |